Evaluate the effectiveness of servo-ventilation therapy in patients with co-existing sleep related breathing disorders and heart failure: a 6-month longitudinal case-control observational study

Phillips Respironics International Inc. (France)0 个研究点目标入组 40 人开始时间: 2010年4月22日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. Patients with heart failure and obstructive/central sleep apnoea (no specific age range or sex)
•2. Naive patients to positive airway pressure therapy
•3. Apnoea/Hypopnoea Index greater than 30/h with at least 30% of central events
•4. Left ventricular ejection fraction less than 45%
•5. Patients with a New York Heart Association (NYHA) class between II and IV
•6. Stable and optimised medical cardiac therapy since one month at least
•7. Informed consent signed

•1. Patients with associated chronic obstructive pulmonary disease
•2. Patients with unstable heart failure or stable since less than one month
•3. Patients with unstable angina pectoris or stable since less than one month
•4. Patients with stroke
•5. Patients with ischaemic cardiomyopathy or cardiogenic oedema
•6. Patients with a cardiac resynchronisation scheduled within the next 6 months
•7. Patients with a valvular surgery scheduled within the next 6 months
•8. Patients participating to another clinical trial or not affiliated to the social security system
•9. Patients in jail or hospitalised without consent
•10. Majors protected by the law or detainees
•11. Minors
•12. Pregnant or nursing women

发起方

Phillips Respironics International Inc. (France)